Sweden: Liwendahl to join Immunovia as CFO by latest April 2022

Immunovia, a diagnostic company that develops and sells blood tests for the early detection of cancer, has announced that Karin Almqvist Liwendahl will join Immunovia as CFO. She will take up the position at the latest by April 1, 2022.

Liwendahl has a background in the telecom industry and life sciences. Most recently she was CFO of the medical technology company Dignitana, which she joined in November 2020. She has also been Financial Advisor and CFO at Sprint Bioscience and Interim CFO of Kontigo Care. Liwendahl gained experience at Telia over 15 years including Director, Corporate Treasury, Telia Company, CFO of Telia Carrier, Managing Director and Country Manager of Telia Carrier in Russia. She was also Head of Investor Relations at Ericsson between 1994 and 2000.


Current CFO Hans Liljenborg will continue with Immunovia in the position as Finance Director.

“With her deep experience of leading and developing finance functions and strong background in Investor Relations, I am convinced that she will make an important impact on our business. As we move forward, we need to continue to strengthen our communications with the investor community, nationally and internationally,” said Patrik Dahlen, CEO of Immunovia.